Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2006 Nov 21;12(43):7012-8.
doi: 10.3748/wjg.v12.i43.7012.

Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients

Affiliations
Clinical Trial

Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients

Yesuf Taha et al. World J Gastroenterol. .

Abstract

Aim: To study the effect of oral steroids upon clinical response and rectal mucosa secretion of eosinophil cationic protein (ECP), myeloperoxidase (MPO), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and albumin in patients with collagenous colitis (CC).

Methods: A segmental perfusion technique was used to collect perfusates from rectum of CC patients once before and twice (one and four weeks) after the start of steroid treatment. Clinical data was monitored and ECP, MPO, bFGF, VEGF and albumin concentrations were analyzed by immunochemical methods in perfusates and in serum.

Results: Steroids reduced the number of bowel movements by more than five times within one week and all patients reported improved subjective well-being at wk 1 and 4. At the same time, the median concentrations of ECP, bFGF, VEGF and albumin in rectal perfusates decreased significantly. MPO values were above the detection limit in only 3 patients before treatment and in none during treatment. VEGF, bFGF, ECP and albumin concentrations correlated with each other with the exception of ECP and albumin. A decrease of serum ECP and VEGF concentrations was also seen even if the overtime reduction was not significant.

Conclusion: Oral steroid treatment in CC patients induced a simultaneous reduction of bowel movements and rectal release of ECP, bFGF, VEGF and albumin, suggesting that these polypeptides and increased mucosal permeability are important components of the pathophysiology in collagenous colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The individual values of basic fibroblast growth factor (bFGF) concentrations in perfusion fluids from rectum of collagenous colitis (CC) patients before and after one and four weeks of steroid treatment. The bars indicate median values. The dotted line indicates the detection limit for the assay (bFGF: 0.25 pg/mL).
Figure 2
Figure 2
The individual values of vascular endothelial growth factor (VEGF) concentrations in perfusion fluids from rectum of collagenous colitis (CC) patients before and after one and four weeks of steroid treatment. The bars indicate median values. The dotted line indicates the detection limit for the assay (VEGF: 9 pg/mL).

Similar articles

Cited by

References

    1. Jawhari A, Talbot IC. Microscopic, lymphocytic and collagenous colitis. Histopathology. 1996;29:101–110. - PubMed
    1. Bogomoletz WV. Collagenous, microscopic and lymphocytic colitis. An evolving concept. Virchows Arch. 1994;424:573–579. - PubMed
    1. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol. 1987;18:839–848. - PubMed
    1. Aigner T, Neureiter D, Müller S, Küspert G, Belke J, Kirchner T. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology. 1997;113:136–143. - PubMed
    1. Tagkalidis P, Bhathal P, Gibson P. Microscopic colitis. J Gastroenterol Hepatol. 2002;17:236–248. - PubMed

Publication types

MeSH terms